Switching to new tenofovir alafenamide keeps virus in check and improves kidney and bone health
Raltegravir appears to prevent mother-to-child HIV transmission during late pregnancy
PrEP demo project finds the people at highest HIV risk generally take PrEP most consistently
Vancouver's treatment as prevention success is also due to harm reduction and addiction treatment
HIV self-testing may help the 'hard to reach' learn their status, but uncertainties remain
Peer-led network intervention substantially lowers HIV infections in people who use drugs in Ukraine
Gay youth PrEP study finds good retention and reasonable adherence
Giving people information about HIV treatment as prevention lessens stigma and increases testing rates
New NNRTI doravirine suppresses HIV as well as efavirenz but with fewer central nervous system side-effects
